BLEOMYCIN
UNII 40S1VHN69B

Substance Identification & Data

This profile provides standardized clinical and technical data for Bleomycin, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 40S1VHN69B.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 11056-06-7 and the RxNorm Concept ID (RxCUI) 1622. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
40S1VHN69B
CAS Registry Number
11056-06-7
RxNorm Concept ID

Detailed Substance Profile

Preferred Name
BLEOMYCIN
Official standardized name for this substance within the FDA UNII nomenclature system.
Molecular Formula
40S1VHN69B
The specific atomic composition represented as a molecular structure string.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
2721
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
mixture
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Bleomycin. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

BLEOMYCIN

Common Names & Synonyms

BLEOMYCIN [HSDB]
BLEOMYCIN [IARC]
BLEOMYCIN [INN]
BLEOMYCIN [VANDF]
BLEOMYCIN [WHO-DD]
BLEOMYCIN HYDROCHLORIDE [JAN]
BLEOMYCINS
BLEOMYCINS [IARC]
BLEOMYCINS [MI]
MIXTURE OF CYTOTOXIC GLYCOPEPTIDES PRODUCED BY THE GROWTH OF STREPTOMYCES VERTICILLUS

Brand / Trade Names

BLENAMAX
BLEO
BLEOCIN
BLEOMYCIN HEXAL

Technical Codes

NSC-125066

NDC Products Containing BLEOMYCIN

This unique ingredient identifier is listed as an ingredient or substance in the following products in the NDC directory: